← Back to search
1kv5

Structure of Trypanosoma brucei brucei TIM with the salt-bridge-forming residue Arg191 mutated to Ser

Method: X-RAY DIFFRACTION Dmax: 79.9 Å Quality: GOOD
▼

1. Protein Identity and Related Structures Protein Identity & Related Structures

triosephosphate isomerase, glycosomal

Trypanosoma brucei brucei

UniProt P04789

State in the Current Structure

Assembly Oligomeric State Construct Mutations and Modifications Ligands, Ions and Associated Components Method and Experimental Conditions Structure Quality
1 Protein homooligomer Homooligomer Protein × 2 PDB declaration: dimeric（2） Consistent with protein copy count Chain A； UniProt 1–250 Chain B； UniProt 1–250 Mutation：R191S PGA 2-PHOSPHOGLYCOLIC ACID × 2 DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 GOL GLYCEROL × 4 SO4 SULFATE ION × 1 X-RAY DIFFRACTION X-ray crystallization conditions：VAPOR DIFFUSION, HANGING DROP；pH 5.5；295 K；ammonium sulfate, sodium chloride, citric acid, pH 5.5, VAPOR DIFFUSION, HANGING DROP at 295K Resolution 1.65 Å R-free 0.175

Other States of the Same Protein in the Database

Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.

Other PDB Difference from Current Entry 1KV5 Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Method and Experimental Conditions Structure Quality
1AG1 MONOHYDROGEN PHOSPHATE BINDING TO TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE Deposited 1997-03-28 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain O 1–250（250 aa）
Chain T 1–250（250 aa）
Not recorded PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；2.4 M AMMONIUM SULFATE IN 0.2 MOPS BUFFER, PH 7.0 FOLLOWED BY TRANSFER TO 44% PEG-6000 CONTAINING 15 MM PHOSPHATE
Resolution 2.36 Å
1DKW CRYSTAL STRUCTURE OF TRIOSE-PHOSPHATE ISOMERASE WITH MODIFIED SUBSTRATE BINDING SITE Deposited 1999-12-08 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 2–250（249 aa）
Chain B 2–250（249 aa）
Not recorded TBU TERTIARY-BUTYL ALCOHOL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；1.0 M CITRIC ACID PH 6.5, 20% PEG6000, 2.5% T-BUTANOL, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.65 Å R-free 0.242
1IIG STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH 3-PHOSPHONOPROPIONATE Deposited 2001-04-23 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded 3PP 3-PHOSPHONOPROPANOIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.60 Å
1IIH STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATE ISOMERASE COMPLEXED WITH 3-PHOSPHOGLYCERATE Deposited 2001-04-23 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded 3PG 3-PHOSPHOGLYCERIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.20 Å
1ML1 PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATE ISOMERASE: THE MODELLING AND STRUCTURE VERIFICATION OF A SEVEN RESIDUE LOOP Deposited 1996-09-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain C 1–250（250 aa）
Not recorded PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；PLEASE SEE JRNL ARTICLE, pH 7.5
Resolution 2.60 Å R-free 0.247
1ML1 PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATE ISOMERASE: THE MODELLING AND STRUCTURE VERIFICATION OF A SEVEN RESIDUE LOOP Deposited 1996-09-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain E 1–250（250 aa）
Chain G 1–250（250 aa）
Not recorded PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；PLEASE SEE JRNL ARTICLE, pH 7.5
Resolution 2.60 Å R-free 0.247
1ML1 PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATE ISOMERASE: THE MODELLING AND STRUCTURE VERIFICATION OF A SEVEN RESIDUE LOOP Deposited 1996-09-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain I 1–250（250 aa）
Chain K 1–250（250 aa）
Not recorded PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；PLEASE SEE JRNL ARTICLE, pH 7.5
Resolution 2.60 Å R-free 0.247
1MSS LARGE SCALE STRUCTURAL REARRANGEMENTS OF THE FRONT LOOPS IN MONOMERISED TRIOSEPHOSPHATE ISOMERASE, AS DEDUCED FROM THE COMPARISON OF THE STRUCTURAL PROPERTIES OF MONOTIM AND ITS POINT MUTATION VARIANT MONOSS Deposited 1994-07-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
1TPD STRUCTURES OF THE "OPEN" AND "CLOSED" STATE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE, AS OBSERVED IN A NEW CRYSTAL FORM: IMPLICATIONS FOR THE REACTION MECHANISM Deposited 1994-02-28 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.10 Å
1TPD STRUCTURES OF THE "OPEN" AND "CLOSED" STATE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE, AS OBSERVED IN A NEW CRYSTAL FORM: IMPLICATIONS FOR THE REACTION MECHANISM Deposited 1994-02-28 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.10 Å
1TPD STRUCTURES OF THE "OPEN" AND "CLOSED" STATE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE, AS OBSERVED IN A NEW CRYSTAL FORM: IMPLICATIONS FOR THE REACTION MECHANISM Deposited 1994-02-28 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.10 Å
1TPE COMPARISON OF THE STRUCTURES AND THE CRYSTAL CONTACTS OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE IN FOUR DIFFERENT CRYSTAL FORMS Deposited 1994-02-28 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.10 Å
1TPF COMPARISON OF THE STRUCTURES AND THE CRYSTAL CONTACTS OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE IN FOUR DIFFERENT CRYSTAL FORMS Deposited 1994-02-28 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded DMS DIMETHYL SULFOXIDE × 4 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 1.80 Å
1TRD THE INFLUENCE OF CRYSTAL PACKING ON CRYSTALLOGRAPHIC BINDING STUDIES: A NEW CRYSTAL FORM OF TRYPANOSOMAL TIM Deposited 1992-10-06 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1TRD THE INFLUENCE OF CRYSTAL PACKING ON CRYSTALLOGRAPHIC BINDING STUDIES: A NEW CRYSTAL FORM OF TRYPANOSOMAL TIM Deposited 1992-10-06 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 1–250（250 aa）
Not recorded PGH PHOSPHOGLYCOLOHYDROXAMIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1TRD THE INFLUENCE OF CRYSTAL PACKING ON CRYSTALLOGRAPHIC BINDING STUDIES: A NEW CRYSTAL FORM OF TRYPANOSOMAL TIM Deposited 1992-10-06 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Not recorded PGH PHOSPHOGLYCOLOHYDROXAMIC ACID × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å
1TRI THE CRYSTAL STRUCTURE OF AN ENGINEERED MONOMERIC TRIOSEPHOSPHATE ISOMERASE, MONOTIM: THE CORRECT MODELLING OF AN EIGHT-RESIDUE LOOP Deposited 1993-10-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1–250（250 aa）
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
1TSI STRUCTURE OF THE COMPLEX BETWEEN TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE AND N-HYDROXY-4-PHOSPHONO-BUTANAMIDE: BINDING AT THE ACTIVE SITE DESPITE AN "OPEN" FLEXIBLE LOOP Deposited 1992-11-19 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded 4PB N-HYDROXY-4-PHOSPHONO-BUTANAMIDE × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.84 Å
1TTI THREE NEW CRYSTAL STRUCTURES OF POINT MUTATION VARIANTS OF MONOTIM: CONFORMATIONAL FLEXIBILITY OF LOOP-1,LOOP-4 AND LOOP-8 Deposited 1995-04-19 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1–250（250 aa）
Mutation：I68G, A69N, K70A, S71D, DEL(73-79), P81A, A100W PGA 2-PHOSPHOGLYCOLIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
1TTJ THREE NEW CRYSTAL STRUCTURES OF POINT MUTATION VARIANTS OF MONOTIM: CONFORMATIONAL FLEXIBILITY OF LOOP-1,LOOP-4 AND LOOP-8 Deposited 1995-04-20 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 1–250（250 aa）
Mutation：VARIANT OF MONOTIM WITH PHE 45 REPLACED BY SER AND VAL 46 REPLACED BY SER (F45S, V46S) AND 73 - 79 DELETED PGH PHOSPHOGLYCOLOHYDROXAMIC ACID × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.40 Å
2J24 The functional role of the conserved active site proline of triosephosphate isomerase Deposited 2006-08-16 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：YES Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 7；WELL SOLUTION: 0.1 M TEA PH 7.0, 27% PEG 2K MME AND 0.2 M KSCN PROTEIN SOLUTION: 11 MG/ML PROTEIN, 0.02 M TRIS/HCL PH 7.0, 0.1 M NACL, 1 MM DTT, 1 MM EDTA AND 1 MM NAN3.
Resolution 2.10 Å R-free 0.230
2J27 The functional role of the conserved active site proline of triosephosphate isomerase. Deposited 2006-08-16 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：YES Mutation：YES PGA 2-PHOSPHOGLYCOLIC ACID × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 9.5；WELL SOLUTION: 0.1 M CHES PH 9.5, 25 % PEG 1500, 200 MM MGSO4 PROTEIN SOLUTION: 11.5 MG/ML PROTEIN, 20 MM TRIS/HCL PH 7, 100 MM NACL, 1 MM DTT, 1 MM EDTA, 1 MM NAN3 AND 10 MM 2PG
Resolution 1.15 Å R-free 0.190
2V0T The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-05-18 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；0.1 M HEPES PH 7.5, 8% ETHYLENE GLYCOL AND 10% PEG8000
Resolution 2.20 Å R-free 0.238
2V0T The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-05-18 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain C 1–250（250 aa）
Chain E 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 3 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；0.1 M HEPES PH 7.5, 8% ETHYLENE GLYCOL AND 10% PEG8000
Resolution 2.20 Å R-free 0.238
2V0T The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-05-18 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain D 1–250（250 aa）
Chain F 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 2 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；0.1 M HEPES PH 7.5, 8% ETHYLENE GLYCOL AND 10% PEG8000
Resolution 2.20 Å R-free 0.238
2V0T The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-05-18 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain G 1–250（250 aa）
Chain H 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；0.1 M HEPES PH 7.5, 8% ETHYLENE GLYCOL AND 10% PEG8000
Resolution 2.20 Å R-free 0.238
2V2C The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-06-05 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Mutation：YES SO4 SULFATE ION × 6 PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5；0.1 M TEA PH 7.5, 2 % PEG 400, 2.0 M (NH4)2SO4
Resolution 1.89 Å R-free 0.182
2V2D The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-06-05 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–13（13 aa）
Chain A 15–72（58 aa）
Chain A 80–250（171 aa）
Mutation：YES Mutation：YES Mutation：YES PO4 PHOSPHATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.2；1.75 M (NH4)2PO4, PH 8.2
Resolution 2.30 Å R-free 0.270
2V2H The A178L mutation in the C-terminal hinge of the flexible loop-6 of triosephosphate isomerase (TIM) induces a more closed conformation of this hinge region in dimeric and monomeric TIM Deposited 2007-06-06 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 1–13（13 aa）
Chain A 15–72（58 aa）
Chain A 80–250（171 aa）
Chain B 1–13（13 aa）
Chain B 15–72（58 aa）
Chain B 80–250（171 aa）
Chain C 1–13（13 aa）
Chain C 15–72（58 aa）
Chain C 80–250（171 aa）
Mutation：YES Mutation：YES Mutation：YES Mutation：YES Mutation：YES Mutation：YES Mutation：YES Mutation：YES Mutation：YES PGA 2-PHOSPHOGLYCOLIC ACID × 3 CL CHLORIDE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；0.1 M CITRIC ACID PH 5.5, 20% PEG 6K, 3% TERT.BUTANOL
Resolution 1.18 Å R-free 0.187
2V5L Structures of the Open and Closed State of Trypanosomal Triosephosphate Isomerase: as Observed in a New Crystal Form: Implications for the Reaction Mechanism Deposited 2007-07-06 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Not recorded SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.8；18% PEG6000, 200 MM TRIS PH 8.8, 1MM EDTA, 1MM DTT AND 1MM NAN3
Resolution 2.40 Å
2V5L Structures of the Open and Closed State of Trypanosomal Triosephosphate Isomerase: as Observed in a New Crystal Form: Implications for the Reaction Mechanism Deposited 2007-07-06 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Not recorded SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.8；18% PEG6000, 200 MM TRIS PH 8.8, 1MM EDTA, 1MM DTT AND 1MM NAN3
Resolution 2.40 Å
2VEI Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 3 PDB declaration: trimeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain C 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain C 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain C 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain C 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Not recorded SO4 SULFATE ION × 16 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5；0.1 M TRIS/HCL PH 8.5, 1.9 M MGSO4
Resolution 1.89 Å R-free 0.215
2VEK Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 1.60 Å R-free 0.193
2VEK Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES CIT CITRIC ACID × 1 TBU TERTIARY-BUTYL ALCOHOL × 1 ASF 3-(BUTYLSULPHONYL)-PROPANOIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 1.60 Å R-free 0.193
2VEL Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties. Deposited 2007-10-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES CL CHLORIDE ION × 1 PGA 2-PHOSPHOGLYCOLIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.30 Å R-free 0.257
2VEL Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties. Deposited 2007-10-24 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES CL CHLORIDE ION × 1 PGA 2-PHOSPHOGLYCOLIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.30 Å R-free 0.257
2VEM Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES BBR (3-bromo-2-oxo-propoxy)phosphonic acid × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.20 Å R-free 0.247
2VEM Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES BBR (3-bromo-2-oxo-propoxy)phosphonic acid × 1 TBU TERTIARY-BUTYL ALCOHOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.20 Å R-free 0.247
2VEN Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–250（249 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.00 Å R-free 0.237
2VEN Structure-based enzyme engineering efforts with an inactive monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties Deposited 2007-10-25 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–250（249 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES CIT CITRIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 2,5% T-BUTANOL, 0.1 M CITRIC ACID PH 5,5
Resolution 2.00 Å R-free 0.237
2WSQ MonoTIM mutant RMM0-1, dimeric form. Deposited 2009-09-08 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 2–67（66 aa） Fragment：RESIDUES 2-67,84-250
Chain B 84–250（167 aa） Fragment：RESIDUES 2-67,84-250
Chain C 2–67（66 aa） Fragment：RESIDUES 2-67,84-250
Chain C 84–250（167 aa） Fragment：RESIDUES 2-67,84-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.2；303 K；100 MM MES BUFFER PH 6.2, 180 MM LI2SO4, 26 PERCENT PEG 6000, 5 MM DITHIOTHREITOL, 1 MM EDTA AND 1 MM NAN3, AT 30 DEGREES CELSIUS.
Resolution 2.10 Å R-free 0.244
2WSQ MonoTIM mutant RMM0-1, dimeric form. Deposited 2009-09-08 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 2–67（66 aa） Fragment：RESIDUES 2-67,84-250
Chain A 84–250（167 aa） Fragment：RESIDUES 2-67,84-250
Chain D 2–67（66 aa） Fragment：RESIDUES 2-67,84-250
Chain D 84–250（167 aa） Fragment：RESIDUES 2-67,84-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.2；303 K；100 MM MES BUFFER PH 6.2, 180 MM LI2SO4, 26 PERCENT PEG 6000, 5 MM DITHIOTHREITOL, 1 MM EDTA AND 1 MM NAN3, AT 30 DEGREES CELSIUS.
Resolution 2.10 Å R-free 0.244
2WSR MONOTIM MUTANT RMM0-1, MONOMERIC FORM. Deposited 2009-09-08 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–67（66 aa） Fragment：RESIDUES 2-67,84-250
Chain A 84–250（167 aa） Fragment：RESIDUES 2-67,84-250
Mutation：YES Mutation：YES SO4 SULFATE ION × 4 AZI AZIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.2；291 K；100 MM MES BUFFER PH 6.2, 180 MM LI2SO4, 26 PERCENT PEG 6000, 5 MM DITHIOTHREITOL, 1 MM EDTA AND 1 MM NAN3, AT 18 DEGREES CELSIUS.
Resolution 1.65 Å R-free 0.255
2X16 Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2009-12-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE PH 5.5
Resolution 2.13 Å R-free 0.261
2X16 Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2009-12-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE PH 5.5
Resolution 2.13 Å R-free 0.261
2X1R Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 1 X1R 3-(PROPYLSULFONYL)PROPANOIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.98 Å R-free 0.226
2X1R Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 2 X1R 3-(PROPYLSULFONYL)PROPANOIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.98 Å R-free 0.226
2X1S Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES X1S 3-SULFOPROPANOIC ACID × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.93 Å R-free 0.201
2X1S Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES X1S 3-SULFOPROPANOIC ACID × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.93 Å R-free 0.201
2X1T Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.83 Å R-free 0.219
2X1T Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES RES 4-PHOSPHO-D-ERYTHRONOHYDROXAMIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.83 Å R-free 0.219
2X1U Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.84 Å R-free 0.237
2X1U Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase Deposited 2010-01-04 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES SO4 SULFATE ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.84 Å R-free 0.237
2X2G CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC VARIANT OF TRIOSEPHOSPHATE ISOMERASE Deposited 2010-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain A 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain A 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.90 Å R-free 0.224
2X2G CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC VARIANT OF TRIOSEPHOSPHATE ISOMERASE Deposited 2010-01-13 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric
Chain B 2–13（12 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 15–72（58 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 80–234（155 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Chain B 238–250（13 aa） Fragment：RESIDUES 2-13,15-72,80-234,238-250
Mutation：YES Mutation：YES Mutation：YES Mutation：YES 3PG 3-PHOSPHOGLYCERIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 5.5；20% PEG6000, 0.1M CITRATE, PH 5.5
Resolution 1.90 Å R-free 0.224
2Y6Z Crystallographic structure of GM23 an example of Catalytic migration from TIM to thiamin phosphate synthase. Deposited 2011-01-27 Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Mutation：YES TPS THIAMIN PHOSPHATE × 2 POP PYROPHOSPHATE 2- × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5；PROTEIN WAS CRYSTALLIZED FROM 2 M LI2SO4, 100 MM MES, PH 6.5
Resolution 2.60 Å R-free 0.235
2Y70 CRYSTALLOGRAPHIC STRUCTURE OF GM23, MUTANT G89D, AN EXAMPLE OF CATALYTIC MIGRATION FROM TIM TO THIAMIN PHOSPHATE SYNTHASE. Deposited 2011-01-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Chain C 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 2 ACT ACETATE ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5；PROTEIN WAS CRYSTALLIZED FROM 2M LI2SO4, 100 MM MES, PH 6.5
Resolution 2.30 Å R-free 0.230
2Y70 CRYSTALLOGRAPHIC STRUCTURE OF GM23, MUTANT G89D, AN EXAMPLE OF CATALYTIC MIGRATION FROM TIM TO THIAMIN PHOSPHATE SYNTHASE. Deposited 2011-01-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：YES Mutation：YES SO4 SULFATE ION × 2 ACT ACETATE ION × 10 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5；PROTEIN WAS CRYSTALLIZED FROM 2M LI2SO4, 100 MM MES, PH 6.5
Resolution 2.30 Å R-free 0.230
3Q37 Identification of Amino Acids that Account for Long-Range Interactions in Proteins Using Two Triosephosphate Isomerases from Pathogenic Trypanosomes. Deposited 2010-12-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Insufficient information Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 2–35（34 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain A 92–119（28 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain B 2–35（34 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain B 92–119（28 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；278 K；0.2 Sodium malonate, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 278K
Resolution 1.65 Å R-free 0.220
3Q37 Identification of Amino Acids that Account for Long-Range Interactions in Proteins Using Two Triosephosphate Isomerases from Pathogenic Trypanosomes. Deposited 2010-12-21 Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Insufficient information Homooligomer；Protein × 2 PDB declaration: dimeric
Chain C 2–35（34 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain C 92–119（28 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain D 2–35（34 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Chain D 92–119（28 aa） Fragment：UNP P04789 residues 2-35 and 92-119, UNP P52270 residues 35-92 and 121-251
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 7；278 K；0.2 Sodium malonate, 20% PEG 3350, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 278K
Resolution 1.65 Å R-free 0.220
3TIM THE CRYSTAL STRUCTURE OF THE "OPEN" AND THE "CLOSED" CONFORMATION OF THE FLEXIBLE LOOP OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE Deposited 1990-05-15 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.80 Å
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：E104D Mutation：E104D SO4 SULFATE ION × 1 PEG DI(HYDROXYETHYL)ETHER × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain C 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：E104D Mutation：E104D SO4 SULFATE ION × 2 PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 3 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain E 1–250（250 aa）
Chain F 1–250（250 aa）
Mutation：E104D Mutation：E104D PEG DI(HYDROXYETHYL)ETHER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 4 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain G 1–250（250 aa）
Chain H 1–250（250 aa）
Mutation：E104D Mutation：E104D SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 5 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain I 1–250（250 aa）
Chain J 1–250（250 aa）
Mutation：E104D Mutation：E104D No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4JEQ Different Contribution of Conserved Amino Acids to the Global Properties of Homologous Enzymes Deposited 2013-02-27 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 6 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain K 1–250（250 aa）
Chain L 1–250（250 aa）
Mutation：E104D Mutation：E104D SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP；pH 8.6；281.15 K；25% w/v PEG monomethyl ether 2000, 0.1 M Tris, 0.01 M Nickel (II) chloride hexahydrate, 5% w/v n-dodecyl-N,N-dimethylamin-N-oxide , pH 8.6, VAPOR DIFFUSION, SITTING DROP, temperature 281.15K
Resolution 2.30 Å R-free 0.261
4TIM CRYSTALLOGRAPHIC AND MOLECULAR MODELING STUDIES ON TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE: A CRITICAL ASSESSMENT OF THE PREDICTED AND OBSERVED STRUCTURES OF THE COMPLEX WITH 2-PHOSPHOGLYCERATE Deposited 1991-04-11 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded 2PG 2-PHOSPHOGLYCERIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions THE CRYSTALS USED FOR THIS STRUCTURE DETERMINATION WERE GROWN IN THE PRESENCE OF 2.4M AMMONIUM SULFATE (SEE PROTEIN DATA BANK ENTRIES 2TIM AND 5TIM), BUT BEFORE DATA COLLECTION THESE CRYSTALS WERE TRANSFERRED TO A MOTHER LIQUOR WITHOUT SULFATE CONTAINING 30MM 2-PHOSPHOGLYCERATE. THE ACTIVE SITE OF CHAIN *A* ("OPEN"-CONFORMATION) HAS NO BOUND 2-PHOSPHOGLYCERATE. THE ACTIVE SITE OF CHAIN *B* ("CLOSED"-CONFORMATION) HAS A BOUND 2-PHOSPHOGLYCERATE.
Resolution 2.40 Å
5I3F Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：I172A Mutation：I172A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；287 K；20-30% MePEG 5000, 50 mM MES
Resolution 1.72 Å R-free 0.227
5I3F Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain C 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：I172A Mutation：I172A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；287 K；20-30% MePEG 5000, 50 mM MES
Resolution 1.72 Å R-free 0.227
5I3G Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain C 1–250（250 aa）
Mutation：I172A,L232A Mutation：I172A,L232A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；287 K；15-25% Peg 8000, 50-100 mM potassium acetate, 100 mM BTP pH 7.0
Resolution 1.96 Å R-free 0.222
5I3G Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：I172A,L232A Mutation：I172A,L232A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；287 K；15-25% Peg 8000, 50-100 mM potassium acetate, 100 mM BTP pH 7.0
Resolution 1.96 Å R-free 0.222
5I3H Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：I172A, L232A Mutation：I172A, L232A K POTASSIUM ION × 2 PGA 2-PHOSPHOGLYCOLIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 7；287 K；15-25% Peg 8000, 50-100 mM potassium acetate, 100 mM BTP pH 7.0
Resolution 2.25 Å R-free 0.211
5I3I Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：I172A Mutation：I172A PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；287 K；20-30% MePEG 5000, 2-4% PEP, 50 mM MES
Resolution 2.20 Å R-free 0.249
5I3I Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain C 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：I172A Mutation：I172A PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 6；287 K；20-30% MePEG 5000, 2-4% PEP, 50 mM MES
Resolution 2.20 Å R-free 0.249
5I3J Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Mutation：L232A Mutation：L232A NA SODIUM ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；287 K；20-30% Peg 4000, 150-250 mM NaCl, 50 mM Epps
Resolution 1.80 Å R-free 0.211
5I3K Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain D 1–250（250 aa）
Mutation：L232A Mutation：L232A NA SODIUM ION × 2 PGA 2-PHOSPHOGLYCOLIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；287 K；20-30% Peg 4000, 150-250 mM NaCl, 50 mM Epps
Resolution 2.21 Å R-free 0.264
5I3K Structure-Function Studies on Role of Hydrophobic Clamping of a Basic Glutamate in Catalysis by Triosephosphate Isomerase Deposited 2016-02-10 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 2 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain B 1–250（250 aa）
Chain C 1–250（250 aa）
Mutation：L232A Mutation：L232A NA SODIUM ION × 1 PGA 2-PHOSPHOGLYCOLIC ACID × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP；pH 8；287 K；20-30% Peg 4000, 150-250 mM NaCl, 50 mM Epps
Resolution 2.21 Å R-free 0.264
5TIM REFINED 1.83 ANGSTROMS STRUCTURE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE, CRYSTALLIZED IN THE PRESENCE OF 2.4 M-AMMONIUM SULPHATE. A COMPARISON WITH THE STRUCTURE OF THE TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE-GLYCEROL-3-PHOSPHATE COMPLEX Deposited 1991-04-23 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded SO4 SULFATE ION × 2 DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 1.83 Å
6TIM THE ADAPTABILITY OF THE ACTIVE SITE OF TRYPANOSOMAL TRIOSEPHOSPHATE ISOMERASE AS OBSERVED IN THE CRYSTAL STRUCTURES OF THREE DIFFERENT COMPLEXES Deposited 1991-04-23 Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics Assembly 1 Protein homooligomer Homooligomer；Protein × 2 PDB declaration: dimeric
Chain A 1–250（250 aa）
Chain B 1–250（250 aa）
Not recorded G3P SN-GLYCEROL-3-PHOSPHATE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions THIS STRUCTURE IS OBTAINED FROM CRYSTALS GROWN IN 2.4M AMMONIUM SULPHATE AND TRANSFERRED INTO SULPHATE FREE MOTHER LIQUOR CONTAINING 6MM DL-GLYCEROL-3-PHOSPHATE.
Resolution 2.20 Å

48 other PDB entries and 80 assemblies. Open the comparison page and filter oligomeric states

View Construct and Data Evidence
UniProt name TPIS_TRYBB
Isoform —
PDB entities 1
Chains and sequence ranges Author chain A； PDBConstruct 1–250； UniProt 1–250 Author chain B； PDBConstruct 1–250； UniProt 1–250

The page prioritizes protein identity, the current assembly, associated components, oligomeric state and cross-PDB links. Chain mapping and sequence ranges are retained as data evidence. Internal IDs, import timestamps and assembly operation expressions are maintenance fields and are not shown here.

SAXS scattering curve SAXS Profile

SAXS profile for 1kv5

P(r) Distance Distribution P(r) Distribution

P(r) distribution for 1kv5
Download Download
▼

2. Structure Basics 2. Structure Basics

Entry ID entry_id1kv5
Deposition date deposition_date2002-01-25
Structure title titleStructure of Trypanosoma brucei brucei TIM with the salt-bridge-forming residue Arg191 mutated to Ser
Keywords keywordsTIM barrel, mutant, salt bridge, isomerase; ISOMERASE
Experimental Method methodX-RAY DIFFRACTION
▼

3. SAXS Parameters (CRYSOL theoretical calculation) 3. SAXS Parameters (CRYSOL)

Radius of gyration Rg (Guinier) rg_guinier25.58 Å
Radius of gyration Rg (electron density) rg_electron24.55 Å
Forward intensity I(0) i047815600.00
Molecular weight molecular_weight54208.0 kDa
Excluded volume excluded_volume68196 ų
Envelope volume envelope_volume77867 ų
Hydration-shell volume shell_volume26744 ų
Envelope diameter envelope_diameter82.2 Å
Shell Rg shell_rg31.72 Å
Envelope Rg envelope_rg24.75 Å
Shape Rg shape_rg24.53 Å
Total Rg total_rg25.42 Å
Total atoms total_atoms3811
Residues n_residues498
Spherical-harmonic order n_harmonics20
q range q_range— – 0.5000 Å−1
Data points n_points101
Shell type shell_typedirectional
Solvent electron density solvent_density0.3340 e/ų
Shell contrast contrast_shell0.0300 e/ų
CRYSOL version crysol_version4.1.3
▼

4. P(r) Distance Distribution (GNOM inversion) 4. P(r) Analysis (GNOM)

Maximum dimension Dmax dmax79.9 Å
Rg (real space) rg_real25.62 Å
Rg uncertainty (real space) rg_real_error0.44 Å
I(0) (real space) i0_real4.7820e+07
I(0) uncertainty (real space) i0_real_error6.4520e+05
Rg (reciprocal space) rg_reciprocal25.61 Å
I(0) (reciprocal space) i0_reciprocal47820000.0000
Solution quality estimate total_estimate0.8970
Solution quality rating solution_quality GOOD a GOOD solution
P(r) peaks n_peaks2
Primary peak position r_peak_primary25.8 Å
Skewness Skewness skewness0.382
Kurtosis Kurtosis kurtosis-0.495
Angular range angular_range— – 0.3100 Å−1
Current regularization parameter α current_alpha0.0000
Highest regularization parameter α highest_alpha14140000.0000
Real-space data points n_real_points63
GNOM version gnom_version4.1.3
Quality Criteria quality_criteria AN1: 0.000; Oscil: 0.912; Stabil: 1.000; Sysdev: 1.000; Positv: 1.000; Valcen: 0.986; Smooth: 0.934
▶

5. Crystallography and Experiment 5. Crystallography & Experiment

▶

6. Entities and Polymers Entities & Polymers (6)

▼

7. Fold Classification (SCOP + CATH) 4 domains

SCOP 2.08 (2 domains)

Domain ID domain_idd1kv5a_
Class classc — Alpha and beta proteins (a/b)
Fold Fold foldc.1 — TIM beta/alpha-barrel
Superfamily Superfamily superfamilyc.1.1 — Triosephosphate isomerase (TIM)
Family Family familyc.1.1.1 — Triosephosphate isomerase (TIM)
Domain ID domain_idd1kv5b_
Class classc — Alpha and beta proteins (a/b)
Fold Fold foldc.1 — TIM beta/alpha-barrel
Superfamily Superfamily superfamilyc.1.1 — Triosephosphate isomerase (TIM)
Family Family familyc.1.1.1 — Triosephosphate isomerase (TIM)

CATH v4.4 (2 domains)

Domain ID domain_id1kv5A00
Class class3 — Alpha Beta
Architecture architecture20 — Alpha-Beta Barrel
Topology topology20 — TIM Barrel
Homologous superfamily homologous superfamily70 — Aldolase class I
Domain ID domain_id1kv5B00
Class class3 — Alpha Beta
Architecture architecture20 — Alpha-Beta Barrel
Topology topology20 — TIM Barrel
Homologous superfamily homologous superfamily70 — Aldolase class I
▶

8. Citations (1)

▶

9. Files and Curves (10)